|
|
 |
|
|
|
|
71. G. Heinzel, R. Wolszczak, and P. Rhomann. Topfit version 2.0Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC. Gustav Fischer Verlag, 1993. |
|
|
|
|
|
|
|
|
72. N. H. G. Holford. Parametric models of the time course of drug action in the in vivo study of drug action. C. J. Van Boxtel, N. H. G. Holford, and M. Danhof, Eds. Elsevier, New York, 1992, p. 6169. |
|
|
|
|
|
|
|
|
73. D. A. Noe and K. M. Kumor. A pharmacokinetic-pharmacodynamic model of heart rate during cocaine administration in humans. Clin. Pharm. Therap. 49:426432, 1991. |
|
|
|
|
|
|
|
|
74. P. Francheteaud, S. L. Steiner, H. Merdjan, M. Guerret, C. Dubray, and P. Sassano. A mathematical model for dynamics of cardiovascular drug action with application to intravenous nicardipine in volunteers and hypertensive patients. Poster presentation, IOPHAR Symposium Measurement and Kinetics of in vivo Drug Effects, Noordwjik, Holland, 1990. |
|
|
|
|
|
|
|
|
75. C. H. Kleinbloesem, P. Van Brummelen, M. Danhof, J. Faber, J. Urquhart, and D. D. Breimer. Rates of increase in plasma concentration of nifedipine as a major determinant of its haemodynamic effects in humans. Clin. Pharmacol. Ther. 41: 2630, 1987. |
|
|
|
|
|
|
|
|
76. D. B. Campbell. Unpublished, 1995c. |
|
|
|
|
|
|
|
|
77. M. M. Gupta and D. H. Rao, Fuzzy Sets Systems 61 1, 1994. |
|
|
|
|
|
|
|
|
78. M. E. Brier, J. M. Zurada, and G. R. Aronoff. Neural network predicted peak and trough gentamicin concentrations. Pharm. Res. 12: 406412, 1995. |
|
|
|
|
|
|
|
|
79. M. Costa, C. Della Pepa, P. Zara, and M. Eandi. Artificial neural networks for pharmacokinetic modeling (personal communication), 1995. |
|
|
|
|
|
|
|
|
80. P. Veng-Pederson and N. B. Modi. Neural networks in pharmacodynamic modeling: Is current modeling practice of complex kinetic systems at a dead end? J. Pharmacokin. Biopharm. 20: 397412, 1992. |
|
|
|
|
|
|
|
|
81. J. Faro and S. Velasco. Studies on a recent class of network models of the immune system. J. Theor. Biol. 164: 271290, 1993. |
|
|
|
|
|
|
|
|
82. R. A. Siegal. Commentary on Neural networks in pharmacodynamic modeling: Is current modeling practice of complex kinetic systems at a dead end? J. Pharmacokin. Biopharm. 20: 413418, 1992. |
|
|
|
|
|
|
|
|
83. D. F. Morrison, P. M. Bungay, J. K. Hsiao, I. N. Mefford, K. H. Dykstra, and R. L. Dedrick. Quantitative microdialysis. In Microdialysis in the Neurosciences. T. E. Robinson and J. B. Justice, Eds. Elsevier, New York, 1991, p. 4780. |
|
|
|
|
|
|
|
|
84. S. Saini, R. B. Frankel, D. D. Stark, and J. T. Ferrucci. Magnetism: A primer and review. American J. of Roentgenology 150: 735744, 1988. |
|
|
|
|
|
|
|
|
85. C. B. Higgins, H. Hricak, and C. A. Helms, Eds. Magnetic Resonance. Imaging in the Body. Raven Press, New York, 1992. |
|
|
|
|
|
|
|
|
86. I. L. Pykett. NMR imaging in Medicine. Sci. Am. 246: 7889, 1982. |
|
|
|
|
|
|
|
|
87. P. F. Renshaw, A. R. Guimaraes, M. Fava, J. F. Rosenbaum, J. D. Pearlman, J. G. Flood, P. R. Puopolo, K. Clancy, and R. G. Gonzalez. Accumalation of fluoxitine and norfluoxitine in human brain during therapeutic administration. Am. Psychiatry 149: 1592, 1992. |
|
|
|
|
|
|
|
|
88. C. N. Karson, J. E. O. Newton, P. Mohanakrishnan, J. Sprigg, and A. Komoroski. Fluoxitine and trifluroperazine in the human brain: a 19F-nuclear magnetic resonance spectroscopy study. Psychiatry Res. Neuroimaging 45: 95104, 1992. |
|
|
|
|
|